marketed by BIOCON LIMITED (ALTIUS)
• 1PC
198.05
M.R.P.: ₹220.05
10% Off
Inclusive of all taxes
INSUGEN is a combination of two medications, namely human insulin and isophane insulin which belongs to the class of short-acting and intermediate-acting types of insulin. it works by ensuring rapid and consistent sugar control by facilitating the reuptake of sugar in muscle & fat cells and suppressing sugar production in the liver. the most common side effects are allergic reaction at the
hypersensitivity heart disease kidney disease liver disease.
babies: not applicable
lactation mother: safe if prescribed by your doctor because human studies have shown evidence of a drug that does not affect the baby.
pregnancy: safe if prescribed by your doctor because animal studies have evidence of no side effects to the developing baby.
driving: this medication should be used with caution as it may affect your ability to drive.
do not drive if these symptoms occur.
alcohol: avoid alcohol consumption while using this medication because it is unsafe.
kidney: this medication should be used with caution in patients with kidney disease.
dose adjustment may be needed.
liver: this medication should be used with caution in patients with liver disease.
dose adjustment may be needed.
.
Nausea Rash & itching Lipodystrophy Edema Hypoglycemia Weight gain .
INSUGEN works by ensuring rapid and consistent sugar control by facilitating reuptake of sugar in muscle & fat cells and suppressing the production of sugar in the liver..
If you miss the dose of INSUGEN, consult your doctor immediately..
• take INSUGEN injection 15 minutes before food or within 20 minutes after starting a meal.
• do not stop taking this injection unless told by your doctor.
• do not change your insulin brand unless told by your doctor.
• do not share your insulin injection with others as it may cause severe infections in them.
• opened vials/cartridges must be kept at room temperature for up to 4 weeks, and unopened vials must be kept in the refrigerator with the temperature of 2 °C to 8°C
• carry a sugar source with you for immediate relief from hypoglycemia condition..
major
• human insulin + chloroquine: concurrent use leads to hypoglycemia.
• human insulin + rosiglitazone: concurrent use leads to increased risk of fluid retention & hypoglycemia and heart failure.
moderate
• human insulin + atenolol: concurrent use leads to hyperglycemia.
• human insulin + clofibrate: concurrent use leads to increased risk of hypoglycemia.
.
100% Authentic
Easy Return